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Abstract: Mediterranean spotted fever (MSF) is widely prevalent in many endemic regions in Bulgaria. The disease is 
still not quite thoroughly studied as to some aspects of its pathogenesis and especially to issues that concern the crucial 
signals for apoptosis in the target microvascular endothelial cells. To study the expression of Bcl-2 family proteins and 
Caspase-3 in the dermal capillary endothelial cells from skin papules and in the eschar (tache noire) epidermal layers 
of patients with MSF so that we can establish apoptotic processes and the time of their occurrence and deployment. 
Immunohistochemical reactions for Bcl-2, Bax and Caspase-3 were obtained in slices of punch-biopsies taken from 
papules of the skin rash and from the eschars of eight patients with MSF. The average intensity of the reactions was 
compared with that in control punch-biopsy slices from four healthy subjects. MSF was etiologically confirmed in all 
patients by positive antibody response to a specific antigen, Rickettsia conorii, with indirect immunofluorescent assay 
performed by the Rickettsial Reference Laboratory. The immune reaction for Bcl-2 was found to be poorly expressed 
in the capillary endothelial cells of skin papules of patients without any differences from controls. The expression of 
Bax and Caspase-3 was strongly upregulated in comparison with the controls. The Bcl-2/Bax ratio was significantly 
decreased. Microvascular endothelial cells of the eschar showed similar changes. While the Bcl-2/Bax ratio decreased 
in the epidermal layers of the eschar “tache noire”, there were no changes in the intensity of the immunoreactivity of 
Caspase-3 as compared with controls. The upregulation of Bax and Caspase-3 is an indication of ongoing apoptotic 
processes in the dermal microvascular endothelial cells of MSF patients. The epidermal layers of the eschar showed 
increased sensitivity to apoptosis, however, executive phase of apoptosis did not occur. (Folia Histochemica et Cyto-
biologica 2013, Vol. 51, No. 2, 121–126)
Key words: mediterranean spotted fever, Rickettsia conorii, endothelial cells, eschar, apoptosis, Bcl-2, Bax, 
caspase-3, immunohistochemistry 
Introduction
Mediterranean spotted fever (MSF) caused by Ric-
kettsia conorii conorii transmitted by the brown dog 
tick Rhipicephalus sanguineus has been widely preva-
lent in many endemic regions in Bulgaria for the last 
20 years [1, 2]. Rickettsiae are obligate intracellular 
parasites with prominent tropism for the host vascular 
endothelial cells [3, 4]. The rickettsial diseases are still 
not quite thoroughly studied as to some aspects of 
their pathogenesis and especially to issues that con-
cern the crucial signals for apoptosis in the targeted 
microvascular endothelial cells [4–6]. 
To survive, rickettsiae are capable of either inducing 
or inhibiting apoptosis during different stages of infection 
[4, 7–8]. The programmed cell death in MSF is among the 
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phenomena that are still inadequately elucidated [4–6, 9]. 
We were prompted to conduct the present study by the 
scantiness of studies on apoptosis in the microvascular 
endothelial cells in rickettsial diseases and by practically 
nonexistent research on patients with MSF [10–13]. This 
study is the first in this field in Bulgaria and we have found 
no similar studies available in the pertinent literature. We 
aimed at studying the expression of Bcl-2 family proteins 
and Caspase-3 in the dermal capillary endothelial cells 
from skin papules, as well as in the epidermal layers from 
the eschar (tache noire) of patients with MSF in order 
to find out if apoptotic processes occur there, when they 
occur and how they are deployed.
Material and methods
Rickettsia conorii was confirmed as etiological agent by im-
munofluorescence assay (IFA) in the Rickettsial Reference 
Laboratory of the Military Medical Academy in Sofia. The 
subject of the study was approved by the Ethics Committee at 
the Medical University – Plovdiv. Written informed consent 
was obtained from all participants in the study. 
We examined punch biopsies from skin papules and from 
the inflammatory infiltrate of the eschar taken off the central 
necrotic area in eight patients with MSF (4 men and 4 women, 
aged 28 to 66 years). Punch biopsies taken from matched skin 
areas of 4 healthy subjects served as controls. The following 
selection criteria to the patients enrolled in the study were 
applied:
Inclusion criteria:
—  presence of tache noire and febrile illness with flu-like 
symptoms for 3–4 days prior to the onset of typical ma-
culopapular rash in a patient from an endemic for MSF 
area in a suitable for the disease season; Four fold rise 
of R.conorii antibody titer in double serum samples;
—  first patients’ presentation to the hospital 48 hours after 
the rash onset;
—  lack of antibiotic treatment before the biopsy perfor-
mance.
Exclusion criteria: 
—  patients (control subjects) with underlying chronic 
diseases (chronic renal failure, diabetes mellitus, ische-
mic heart disease, malignancy, trauma, infections and 
rheumatic disease, etc.); patients (control subjects) with 
pre-existing or concurrent skin disorders;
—  whatever treatment except antipyretics before hospita-
lization and biopsy;
—  children (ethical considerations).
The biopsy specimens were processed by standard methods 
and embedded into paraffin. Consecutive 5 μm thick slices 
were prepared, mounted on silane-covered slides and exami-
ned immunohistochemically. We used a mouse ABC staining 
system (sc-2017, kit, Santa Cruz Biotechnology, Dallas, TX, 
USA) and the following primary antibodies in a 1:100 dilution: 
monoclonal antibody Bcl-2 (sc-509, Santa Cruz Biotechnology); 
monoclonal antibody Bax (sc-7480, Santa Cruz Biotechnolo-
gy); monoclonal antibody Caspase-3 (sc-56046, Santa Cruz 
Biotechnology). Additionally, the specimens were stained with 
hematoxylin. The prepared slices were covered with Vector 
Mount (Vector Lab, Burlingame, CA, USA). The micro-
photographic pictures were taken by a Nikon Microphot-SA 
(Tokyo, Japan) microscope, equipped with a Camedia-5050Z 
digital camera (Olympus, Tokyo, Japan). The expression of the 
immune reaction for Bcl-2, Bax and Caspase-3 in the dermal 
vascular endothelial cells and epidermal layers was recorded 
using specialized software ‘DP — Soft’ 3.2 (Olympus,). The 
average intensity of the reaction of 50 randomly selected areas 
in each cross-section was analyzed. The values for the intensity 
of immunochemical reactions for Bcl-2, Bax and Caspase-3 
are presented in relative units. The results (mean ± SD) were 
analyzed with the independent samples t-test and p < 0.05 was 
considered significant.
Results
We investigated the expression of the immune reac-
tion for Bcl-2, Bax and Caspase-3 in tissues from skin 
papules of patients admitted to the hospital 48 hours 
after the onset of rash — a term we considered as 
possibly the earliest for the apoptotic processes occu-
rrence in the skin microvascular endothelial cells. Pa-
tients’ treatment started immediately after the biopsy 
specimens were obtained. Simultaneously, biopsies 
were taken from the tache noire. Visually the immune 
reactions for Bcl-2, Bax and Caspase-3 in the capillary 
endothelial cells were manifested by mild-brownish to 
no staining for Bcl-2 and dark-brown to black coloring 
for Bax and Caspase-3 which corresponded to the data 
of other authors [14, 15] (Figure 1). There was a weak 
expression of the immune reaction for Bcl-2 in the 
capillary endothelial cells of patient skin papules, and 
a similar weak expression in the controls (p > 0.05). 
The expression of the immune reaction for Bax was 
strongly manifested in comparison with the controls 
(p < 0.001). The analysis revealed increased intensity 
of the immunohistochemical reaction for Caspase-3 
in the microvascular endothelium in comparison with 
the controls (p < 0.001) (Figure 2). The ratio of Bcl-2 
to Bax was found to be significantly decreased in pa-
tients (p < 0.001) mainly due to the increased staining 
intensity of the pro-apoptotic protein Bax. Similar to 
the alterations observed in the capillary endothelial 
cells of skin papules were found in the microvascular 
endothelium of the eschar (tache noire). 
The analysis of the immune reaction in the epider-
mal layers of the patients’ eschar “tache noire” showed 
weakened immunostaining for Bcl-2 in keratinocytes 
of the basal and spinous epidermal layers in compari-
son with the controls (p < 0.01). Immunoexpression 
of Bax was increased in the cells of the spinous and 
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Figure 1. Immunohistochemical reactions for Bcl-2 (A, B), Bax (C, D) and Caspase-3 (E, F) in the dermis of skin papules 
of patients with MSF (A, C, E) and control healthy subjects (B, D, F). Arrows — reaction in the dermal capillary endothe-
lial cells. Original magnification × 400
A B
C D
E F
granular layers compared with the controls (p < 0.05). 
Intensity of the reaction for Caspase-3 in all layers did 
not show statistically significant changes in patients 
compared with the controls (Figures 3 and 4).
Discussion
One of the diagnostic features of MSF is the characteristic 
papular (boutonneuse) skin rash. There are capillary and 
lymphatic networks, and nerve endings in the superficial 
papillary layer of the connective part of the skin, the dermis 
[16]. As we searched for signs of apoptosis in the micro-
vascular endothelial cells we obtained the biopsy from the 
patients’ rash papules as these reflect the disrupted capillary 
permeability, exudation and focal cell infiltration caused 
by the intracellular pathogen R. conorii. In the regulation 
of programmed host-cell death, the B-cell lymphoma-2 
(Bcl-2) family of proteins, which includes both pro- and 
anti-apoptotic factors, plays a crucial role by controlling 
the mitochondrial permeability [17–19]. The anti-apoptotic 
proteins Bcl-2 and Bcl-xL reside in the outer membrane 
of mitochondria; they inhibit the release of cytochrome 
C [20]. In contrast, the pro-apoptotic proteins Bad, Bid 
and Bax are located in the cytosol and their translocation 
to mitochondria causes the release of cytochrome C [21]. 
Determination of the effects of Bcl-2 family on nuclear 
factor NF-kB reveals significant changes in the expression 
of various pro- and anti-apoptotic proteins which ultimately 
results in the so called ‘equilibrium shift’ toward apoptosis 
[22]. It is in this way that the concept of regulation of the 
mechanisms of programmed death of endothelial cells by 
intracellular rickettsiae was proposed [11]. Inhibition of 
apoptosis through activation of nuclear factor NF-kB is 
required for the early phase of the disease when rickettsiae 
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Figure 2. Intensity of the immunoreactivity of Bcl-2, Bax 
and Caspase-3b expression in the capillary endothelial cells 
of the skin papules of MSF patients and control subjects. 
Values represent means ± SD obtained in the way descri-
bed in Material and methods. *p < 0,001 vs. control. RU 
— relative units. Only statistically significant differences 
are shown
Figure 3. Immunohistochemical reactions for Bcl-2 (A, B), Bax (C, D) and Caspase-3 (E, F) in the epidermis of the eschar 
‘tache noire’ of patients with MSF (A, C, E) and controls of healthy subjects (B, D, F). Original magnification × 200
A B
C D
E F
begin to proliferate in the microvascular endothelial cells 
[13, 22–24]. Later, when adaptive immunity is fully deployed 
apoptosis is enhanced in infected endothelial cells [25]. 
We investigated the expression of the immune 
reaction for Bcl-2, Bax and Caspase-3 in tissues from 
skin papules of patients who were hospitalized two 
days after the onset of the rash. We considered two 
days after the rash onset (which is 5–6 days after the 
initial occurrence of the symptoms of MSF) to be 
sufficient for the cell-mediated immune response to 
develop and for anti-apoptotic activity of R. conorii to 
get affected. Therefore we searched for the elements 
of apoptosis in the endothelial cells of the dermal 
microvessels using immunohistochemical reactions 
for the anti-apoptotic protein Bcl-2 and the pro-apo-
ptotic proteins Bax and Caspase-3. Bax is an essential 
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Figure 4. Intensity of the immunoreactivity (mean ± SD) of Bcl-2, Bax and Caspase-3 expression in the epidermal layers 
of the eschar „tache noire” of patients with MSF (shaded bars) and control healthy subjects (open bars). A. Bcl-2,  
*p < 0,01; B. Bax, **p < 0,05; C. Caspase-3. Only statistically significant differences are shown
factor for mitochondria-mediated apoptosis [26–27]. 
The decreased Bcl-2/Bax ratio in the dermal capillary 
endothelial cells of skin papules of MSF patients was 
related to the increased levels (immunoreactivity) of 
the pro-apoptotic protein Bax which is an indicator 
of intensified apoptotic sensitivity and initiation of 
processes of programmed host-cell death. 
While Bcl-2 inhibits apoptosis and Bax promotes 
it, Caspase-3 is known to be an executioner enzyme 
in the apoptotic process [28]. The activation of this 
executioner protease triggers a cascade of proteolytic 
processes that leads to digestion of structural prote-
ins in the cytoplasm, degradation of chromosomal 
DNA of the cell and phagocytosis [29]. The observed 
increased intensity of immunochemical reaction for 
Caspase-3 in the capillary endothelial cells of the rash 
papules indicates activation of apoptotic processes 
and signals early transition to the next stage of the 
apoptotic cascade that leads to cell death. In light of 
these considerations, the studied apoptosis markers 
of microvascular endothelium should attest to the 
disease process with early or full deployment of T-cell 
mediated immune response [25]. However, no altered 
expression of Caspase-3 in the three epidermal layers 
of the eschar was found as compared with controls. 
Thus, the epidermis of the eschar (tache noire) shows 
increased susceptibility to apoptosis, but the actual 
process of apoptosis does not take place. These facts 
suggest that the mechanisms of apoptosis induced in 
the epidermis as a consequence of rickettsial infection 
are not identical to the mechanisms triggering apop-
tosis processes in vascular endothelium. 
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In conclusion, determining the time of initiation 
of the apoptotic processes in the microvascular en-
dothelium of patients is important to detect early 
cell-mediated processes in the body’s defence against 
the intracellular pathogen — R. conorii. The delay of 
apoptotic processes could indicate a failure of the im-
mune system, or a more severe course of the disease, 
or the occurrence of complications. 
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